Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi AventisfiledCriticalSanofi Aventis
Priority to UY30852ApriorityCriticalpatent/UY30852A1/en
Publication of UY30852A1publicationCriticalpatent/UY30852A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La invencion tiene como objetivo una nueva utilizacion terapéutica para el tratamiento de las leucemias, principalmente de las leucemias mieloides.The invention aims at a new therapeutic use for the treatment of leukemias, mainly myeloid leukemias.
UY30852A2007-12-282007-12-28
NEW THERAPEUTIC USE FOR THE TREATMENT OF LEUKEMIES
UY30852A1
(en)
Substituted 2-amino-acetamide derived compounds; pharmaceutical composition; Useful in the treatment of lung diseases, rheumatic disease, autoimmune disease, among others.